Business Context and Reporting Period
This Form 6-K filing, dated July 30, 2026, serves as the Notice of the 2026 Annual General Meeting of Shareholders for ICL Group Ltd., scheduled for September 17, 2026. The document includes a Proxy Statement summarizing the company's financial performance for the full year 2025 and the first quarter of 2026, alongside updates on strategic direction, corporate governance, and executive compensation.
Key Financial Metrics
Full Year 2025 Performance
- Sales: $7.2 billion (up 5% year-over-year).
- Adjusted EBITDA: $1.5 billion (increase year-over-year).
- Adjusted Diluted EPS: $0.36.
- Net Income (Attributable to Shareholders): $226 million.
- Dividends Distributed: $224 million total (yield of 3.1%).
First Quarter 2026 Performance
- Sales: $2.0 billion (up 14% year-over-year).
- Adjusted EBITDA: $412 million (up 15% year-over-year).
- Adjusted Diluted EPS: $0.11.
- Dividends Distributed (H1 2026): $129 million ($60 million in March, $69 million in June).
Capital Structure and Liquidity
The filing does not provide specific values for total debt, cash flow from operations, or current liquidity ratios. It notes that approximately 73 million ordinary shares held by the controlling shareholder, Israel Corp., have been pledged to secure liabilities with an aggregate outstanding principal of $150 million.
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 5% in 2025 and 14% in Q1 2026, driven by growth across all four business segments.
- Profitability: Adjusted EBITDA grew in 2025 and accelerated in Q1 2026 (+15% YoY).
- Strategic Shift: The company completed a strategic review identifying two primary growth engines: Specialty Crop Nutrition (Growing Solutions) and Specialty Food Solutions (Phosphate Solutions).
- Acquisitions and Expansion: Completed the acquisition of Bartek Ingredients (food-grade malic and fumaric acids) and launched a new water-soluble fertilizers plant in India.
- Dead Sea Concession: Signed a binding agreement regarding Dead Sea Concession assets, reducing uncertainty.
Guidance, Outlook, and Risks
Guidance and Outlook
Following strong Q1 2026 results, ICL increased its full-year 2026 Adjusted EBITDA guidance to a range of $1.5 billion to $1.7 billion. Management expects sustainable growth through strategic acquisitions and organic initiatives in the identified growth engines while maximizing value in core businesses like Potash and Industrial Products.
Management Commentary
CEO Elad Aharonson highlighted the company's ability to navigate diverse markets and its focus on portfolio optimization. The company is reallocating resources to high-potential opportunities and reevaluating non-synergistic activities.
Risks and Contingencies
- Forward-Looking Statements: The filing includes standard disclaimers that actual results may differ due to risks discussed in the 2025 Annual Report.
- Regulatory and Concession Risks: The company is preparing for the expiration of the Dead Sea concession and the allocation process for a new concession in 2030.
- Security Situation: Adjustments to financial measures include transaction costs related to the security situation in Israel.
Investor Verification Checklist
- Guidance Feasibility: Verify the achievability of the raised 2026 Adjusted EBITDA guidance ($1.5B–$1.7B) given current market conditions.
- Dead Sea Concession: Review the details of the binding agreement regarding Dead Sea assets and the timeline for the 2030 concession allocation.
- Debt and Pledges: Investigate the full extent of the $150 million margin loans secured by the controlling shareholder's pledged shares and any potential impact on control stability.
- Non-IFRS Reconciliation: Review Appendix A to understand the specific adjustments made to reach Adjusted EBITDA and Adjusted Net Income, particularly regarding security situation costs and impairments.
- Executive Turnover: Note the departure of CFO Aviram Lahav (June 2026) and the appointment of Asaf Alperovitz; assess the transition impact on financial reporting.